2 Revolutionary Biotech Stocks to Buy Right Now
Here's a simple argument for why long-term investors should consider buying shares of biotech companies. Since its inception in 2006, the SPDR S&P Biotech Index -- an industry benchmark -- has crushed the S&P 500, as the graph below shows.
Source Fool.com